Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia

Published:2014-12 Issue:12 Volume:20 Page:2042-2048
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Chen Yi-Bin,Li Shuli,Lane Andrew A.,Connolly Christine,Del Rio Candice,Valles Betsy,Curtis Morgan,Ballen Karen,Cutler Corey,Dey Bimalangshu R.,El-Jawahri Areej,Fathi Amir T.,Ho Vincent T.,Joyce Amy,McAfee Steven,Rudek Michelle,Rajkhowa Trivikram,Verselis Sigitas,Antin Joseph H.,Spitzer Thomas R.,Levis Mark,Soiffer Robert

Funder

National Institutes of Health

National Cancer Institute Leukemia

Jock and Bunny Adams Research and Education Endowment

Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center

NIH

National Center for Research Resources

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference41 articles.

1. The roles of FLT3 in hematopoiesis and leukemia;Gilliland;Blood,2002

2. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product;Kiyoi;Leukemia,1998

3. FLT3: ITDoes matter in leukemia;Levis;Leukemia,2003

4. Treatment of FLT3-ITD acute myeloid leukemia;Fathi;Am J Blood Res,2011

5. FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?;Levis;Hematology Am Soc Hematol Educ Program,2013

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in allogeneic transplantation for acute myeloid leukemia;Current Opinion in Oncology;2023-08-30

2. Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party;Clinical Cancer Research;2023-08-21

3. Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation—Immune signature correlates with response;British Journal of Haematology;2023-08-04

4. Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial;The Lancet Haematology;2023-08

5. The roles of TPL in hematological malignancies;Hematology;2023-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3